Enliven Therapeutics Inc.

NASDAQ: ELVN · Real-Time Price · USD
20.24
0.47 (2.38%)
At close: Aug 15, 2025, 3:59 PM
20.22
-0.10%
After-hours: Aug 15, 2025, 06:46 PM EDT

Enliven Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-11.9 -6.87 -2.71 -2.85
PEG Ratio
1.99 0.10 -0.03 0.11
PS Ratio
n/a n/a n/a n/a
PB Ratio
3.42 2.00 -1.33 -1.64
P/FCF Ratio
-14.46 -8.01 -3.13 -3.64
P/OCF Ratio
-14.47 -8.03 -3.19 -3.68
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
n/a 0.00 -0.00 -0.00
Quick Ratio
19.99 10.28 8.00 19.24
Current Ratio
19.99 10.28 8.00 19.24
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.29 -0.29 0.49 0.58
Return on Assets
-0.27 -0.26 -0.45 -0.22
Return on Invested Capital
-0.34 -0.34 -0.5 -0.23
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a